The Glow Blend combines GHK-Cu and TB-500 — two peptide research compounds that target skin and tissue regeneration through complementary pathways. Rather than doubling up on the same mechanism, the combination addresses multiple independent bottlenecks in the repair and remodeling process.
GHK-Cu: Collagen Induction and Matrix Remodeling
GHK-Cu stimulates collagen types I, III, and IV, elastin, and glycosaminoglycans via TGF-β1 and Smad signaling. It modulates over 4,000 human genes with a pattern favoring tissue remodeling and anti-inflammatory signaling, suppresses NF-κB, and activates coordinated MMP and TIMP-2 activity to remodel damaged extracellular matrix. Its plasma concentration declines sharply with age — a decline correlated with reduced regenerative capacity.
TB-500: Cell Migration, Actin Dynamics, and Angiogenesis
TB-500 modulates the G:F actin equilibrium by sequestering G-actin, driving directed lamellipodia formation and accelerated cell migration in keratinocytes, fibroblasts, and endothelial cells. It simultaneously promotes angiogenesis via VEGF upregulation and activates ILK-Akt survival signaling at the wound site. In corneal wound healing (Phase II), Tβ4 eye drops significantly accelerated epithelial healing versus vehicle.
Why the Combination Makes Sense
The mechanistic rationale for combining GHK-Cu and TB-500 rests on non-overlapping activity:
- GHK-Cu addresses the synthetic/remodeling phase: inducing collagen, modulating inflammatory gene expression, coordinating matrix turnover.
- TB-500 addresses the migratory/vascular phase: driving cell recruitment, promoting re-epithelialization, ensuring vascular supply.
- Both suppress inflammatory pathways via distinct mechanisms (NF-κB for GHK-Cu; cytokine reduction for TB-500) — additive anti-inflammatory effect.
- Both independently promote angiogenesis via distinct upstream mechanisms — additive vascularization support.
Research compound:
Glow Blend — View Product Page →References
- Pickart L, Margolina A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide. Int J Mol Sci, 19(7), 1987.
- Goldstein AL, Hannappel E, Kleinman HK. (2005). Thymosin β4 moonlights to repair injured tissues. Trends Mol Med, 11(9), 421–429.
- Sosne G, et al. (2010). Thymosin beta 4 and corneal wound healing. Ann NY Acad Sci, 1194, 190–198.
- Gorouhi F, Maibach HI. (2009). Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci, 31(5), 327–345.